Benzinga | Nov 10, 2021 07:15AM EST

Barclays Maintains Overweight on Bright Health Gr, Lowers Price Target to $12

Barclays analyst Steve Valiquette maintains Bright Health Gr (NYSE:BHG) with a Overweight and lowers the price target from $17 to $12.